N-Fmoc-O-cycloheptyl-L-serine is a serine derivative bearing a bulky cycloheptyl ether that enhances hydrophobic character and steric demand. The Fmoc group enables straightforward solid-phase incorporation. Researchers introduce this residue to modulate local packing, membrane affinity, or steric shielding. Applications include peptidomimetic design, helix-surface tuning, and structure-property relationship studies.
N-Fmoc-O-cycloheptyl-L-serine is a specialized derivative of serine, featuring an N-terminal 9-fluorenylmethyloxycarbonyl (Fmoc) protecting group and a cycloheptyl modification on the hydroxyl side chain. This compound is designed to enhance the utility of serine in peptide synthesis by providing both steric bulk and increased hydrophobicity, which can influence peptide folding and stability. The unique structure of N-Fmoc-O-cycloheptyl-L-serine makes it an attractive building block for researchers aiming to explore novel peptide architectures, study protein-ligand interactions, or develop advanced biomaterials. Its compatibility with standard Fmoc-based solid-phase peptide synthesis (SPPS) protocols ensures ease of integration into established laboratory workflows, while the cycloheptyl group introduces conformational constraints that can modulate the biological and physicochemical properties of the resulting peptides. With its dual functionality as a protected amino acid and a structural modifier, N-Fmoc-O-cycloheptyl-L-serine serves as a valuable tool for peptide chemists and molecular designers seeking to push the boundaries of peptide science.
Peptide Synthesis: N-Fmoc-O-cycloheptyl-L-serine is widely utilized as a protected amino acid building block in Fmoc-based solid-phase peptide synthesis. Its Fmoc group allows for efficient stepwise elongation of peptide chains, while the cycloheptyl moiety on the serine side chain imparts steric and hydrophobic effects that can influence peptide folding and stability. Researchers leverage this compound to introduce conformational constraints into peptides, facilitating the design of structures with enhanced resistance to enzymatic degradation or altered secondary structure preferences. The ability to incorporate such modified residues enables the synthesis of peptides with tailored bioactivity and improved physicochemical properties, expanding the range of accessible peptide-based research tools.
Peptidomimetic Design: In the development of peptidomimetics, the cycloheptyl modification present in this serine derivative offers a means to mimic or disrupt natural peptide conformations. By replacing standard serine residues with its cycloheptyl analog, scientists can modulate backbone flexibility and side-chain interactions, which is particularly valuable in the study of structure-activity relationships. The increased hydrophobicity and steric bulk introduced by the cycloheptyl group can stabilize specific secondary structures or create novel folding patterns, supporting the design of peptide analogs with enhanced target affinity, selectivity, or metabolic stability. This approach is instrumental in the rational design of peptide-based inhibitors, receptor ligands, or molecular probes.
Protein Engineering: The integration of N-Fmoc-O-cycloheptyl-L-serine into synthetic peptides also finds utility in protein engineering efforts. By incorporating this non-canonical amino acid into defined sequence motifs, researchers can systematically explore the effects of side-chain modification on protein folding, stability, and function. The cycloheptyl group can be used to probe hydrophobic interactions, restrict conformational flexibility, or introduce novel functional sites within engineered proteins or protein fragments. Such studies contribute to a deeper understanding of protein structure-function relationships and support the development of proteins with customized properties for research or industrial applications.
Material Science: Beyond its biological applications, this cycloheptyl-modified serine derivative is valuable in the field of biomaterials and nanotechnology. The unique combination of hydrophobic and conformational features provided by the cycloheptyl group can be harnessed to design self-assembling peptide materials with tailored mechanical, chemical, or surface properties. These materials may serve as scaffolds for tissue engineering, drug delivery vehicles, or components in biosensors. The ability to fine-tune peptide assembly and material characteristics through side-chain engineering broadens the scope of functional biomaterial development and enables innovative solutions in biomedical and technological research.
Chemical Biology Research: N-Fmoc-O-cycloheptyl-L-serine supports a wide array of chemical biology investigations, particularly those focused on probing protein-ligand interactions, mapping functional domains, or developing novel labeling strategies. Its structural distinctiveness allows for the selective introduction of unique chemical handles or steric constraints, facilitating the study of molecular recognition events and the development of site-specific modification techniques. By enabling precise manipulation of peptide and protein structure, this serine derivative empowers researchers to dissect complex biological processes and develop advanced tools for molecular discovery.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.